Oxford Immunotec (OXFD) Tops Q3 EPS by 1c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus
Tweet Send to a Friend
Oxford Immunotec (NASDAQ: OXFD) reported Q3 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
